Intelligence Platform
Patents
Browse 2,147 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 9447144
MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1
granted patentUS 9446048
Methods for treating leukemia and disorders mediated by CBFΞ² and RUNX1 proteins
granted patentUS 9439875
Anxiolytic effect of pterostilbene
granted patentUS 9441041
Use of antagonists of the interaction between HIV GP120 and Ξ±4Ξ²7 integrin
granted patentUS 9439979
Epidermal growth factor receptor (EGFR) and methods of use in adenoviral-associated virus
granted patentUS 9441022
Aegyptin and uses thereof
granted patentUS 9441019
Influenza hemagglutinin protein-based vaccines
granted patentUS 9441050
High-affinity monoclonal anti-prion antibodies
granted patentUS 9441048
Antibody for 3β²-isoLM1 and 3β²,6β²-iso-LD1 gangliosides
granted patentUS 9427476
Multivalent meningococcal conjugates and methods for preparing conjugates
granted patentUS 9428541
Substrate reduction therapy
granted patentUS 9421254
Immunostimulatory combinations of TLR ligands and methods of use
granted patentUS 9415105
Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to
granted patentUS 9415116
Compositions and methods for delivering inhibitory oligonucleotides
granted patentUS 9416190
Mesothelin antibodies and methods for eliciting potent antitumor activity
granted patentUS 9409994
High-affinity monoclonal antibodies to glypican-3 and use thereof
granted patentUS 9409992
Mesothelin domain-specific monoclonal antibodies and use thereof
granted patentUS 9408896
Vaccination of companion animals to elicit a protective immune response against tick infes
granted patentUS 9408901
Compositions, methods and uses for dengue virus serotype-4 constructs
granted patentUS 9409956
Salmonella typhi Ty21a expressing Yersinia pestis F1-V fusion protein and uses thereof
granted patentUS 9402889
Live, oral vaccine for protection against Shigella dysenteriae serotype 1
granted patentUS 9402820
Use of pyruvate or succinate to enhance the efficacy of a hypoxia activated prodrug for th
granted patentUS 9399672
Hepatitis C virus neutralizing antibody
granted patentUS 9394358
Gene signature for predicting prognosis of patients with solid tumors
granted